...

Impact of Fever Prevention in Brain Injured Patients (INTREPID)

Evaluate the Arctic Sun Cooling device for fever prevention to standard of care measures for controlling fever in the ICU


Why this Research Matters

Patients randomized to the fever prevention group will have ArcticGel Pads placed on their body. These will be connected to the Arctic Sun System. The system will be programmed to keep the patient's body temperature at 98.6. Treatment will last for 14 days or until ready to be discharged from the ICU. Standard of care patients will receive standard medical care as prescribed by the medical team.


Who can Participate

Adult

Adult, primary diagnosis of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage


Study ID

Protocol Number: 18-0548
More information available at ClinicalTrials.gov: NCT02996266

Meet the Team

Image of Principal Investigator

Luis Cava Prado, MD

Principal Investigator